nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF2—Integrins in angiogenesis—EDIL3—ankylosing spondylitis	0.0408	0.126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.0174	0.0537	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.0149	0.0461	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.0103	0.0317	CbGpPWpGaD
Pentosan Polysulfate—Optic neuritis—Betamethasone—ankylosing spondylitis	0.00944	0.0139	CcSEcCtD
Pentosan Polysulfate—Raised liver function tests—Methotrexate—ankylosing spondylitis	0.00915	0.0135	CcSEcCtD
Pentosan Polysulfate—FGF4—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00906	0.028	CbGpPWpGaD
Pentosan Polysulfate—Appetite absent—Methotrexate—ankylosing spondylitis	0.00849	0.0125	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Prednisone—ankylosing spondylitis	0.00822	0.0121	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.00726	0.0107	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.00661	0.00976	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.00661	0.00976	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00651	0.0201	CbGpPWpGaD
Pentosan Polysulfate—FGF4—B Cell Activation—CD79A—ankylosing spondylitis	0.0064	0.0198	CbGpPWpGaD
Pentosan Polysulfate—Ecchymosis—Prednisolone—ankylosing spondylitis	0.00629	0.0093	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—KIR3DL1—ankylosing spondylitis	0.00622	0.0192	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00593	0.0183	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.00591	0.0183	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00589	0.0182	CbGpPWpGaD
Pentosan Polysulfate—Oesophagitis—Methylprednisolone—ankylosing spondylitis	0.00583	0.00862	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Triamcinolone—ankylosing spondylitis	0.00578	0.00855	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Methylprednisolone—ankylosing spondylitis	0.00577	0.00853	CcSEcCtD
Pentosan Polysulfate—FGF1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00575	0.0178	CbGpPWpGaD
Pentosan Polysulfate—Amenorrhoea—Prednisone—ankylosing spondylitis	0.00575	0.0085	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—CARD9—ankylosing spondylitis	0.00561	0.0173	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00536	0.0166	CbGpPWpGaD
Pentosan Polysulfate—Oesophagitis—Dexamethasone—ankylosing spondylitis	0.0053	0.00784	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Betamethasone—ankylosing spondylitis	0.0053	0.00784	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Betamethasone—ankylosing spondylitis	0.00525	0.00776	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Dexamethasone—ankylosing spondylitis	0.00525	0.00776	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00525	0.0162	CbGpPWpGaD
Pentosan Polysulfate—Affect lability—Prednisolone—ankylosing spondylitis	0.00497	0.00735	CcSEcCtD
Pentosan Polysulfate—Mood swings—Prednisolone—ankylosing spondylitis	0.00478	0.00707	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Prednisone—ankylosing spondylitis	0.00462	0.00683	CcSEcCtD
Pentosan Polysulfate—Affect lability—Triamcinolone—ankylosing spondylitis	0.00457	0.00676	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Prednisone—ankylosing spondylitis	0.00457	0.00676	CcSEcCtD
Pentosan Polysulfate—Affect lability—Methylprednisolone—ankylosing spondylitis	0.00456	0.00674	CcSEcCtD
Pentosan Polysulfate—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00441	0.00652	CcSEcCtD
Pentosan Polysulfate—Mood swings—Triamcinolone—ankylosing spondylitis	0.0044	0.0065	CcSEcCtD
Pentosan Polysulfate—Mood swings—Methylprednisolone—ankylosing spondylitis	0.00439	0.00649	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—ANTXR2—ankylosing spondylitis	0.00435	0.0134	CbGpPWpGaD
Pentosan Polysulfate—Sweating increased—Prednisolone—ankylosing spondylitis	0.00425	0.00628	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.00422	0.00624	CcSEcCtD
Pentosan Polysulfate—Affect lability—Betamethasone—ankylosing spondylitis	0.00415	0.00613	CcSEcCtD
Pentosan Polysulfate—Affect lability—Dexamethasone—ankylosing spondylitis	0.00415	0.00613	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—CD79A—ankylosing spondylitis	0.00406	0.0126	CbGpPWpGaD
Pentosan Polysulfate—Mood swings—Betamethasone—ankylosing spondylitis	0.00399	0.0059	CcSEcCtD
Pentosan Polysulfate—Mood swings—Dexamethasone—ankylosing spondylitis	0.00399	0.0059	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Methotrexate—ankylosing spondylitis	0.00399	0.0059	CcSEcCtD
Pentosan Polysulfate—Weight increased—Prednisolone—ankylosing spondylitis	0.00397	0.00587	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—KIR3DL1—ankylosing spondylitis	0.00395	0.0122	CbGpPWpGaD
Pentosan Polysulfate—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00391	0.00578	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.0039	0.00577	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Methotrexate—ankylosing spondylitis	0.00382	0.00565	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.00382	0.00565	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00378	0.00559	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—IL1R2—ankylosing spondylitis	0.00377	0.0116	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00374	0.0116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—CD79A—ankylosing spondylitis	0.0037	0.0114	CbGpPWpGaD
Pentosan Polysulfate—Weight increased—Triamcinolone—ankylosing spondylitis	0.00365	0.0054	CcSEcCtD
Pentosan Polysulfate—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00364	0.00539	CcSEcCtD
Pentosan Polysulfate—Affect lability—Prednisone—ankylosing spondylitis	0.00361	0.00534	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—KIR3DL1—ankylosing spondylitis	0.0036	0.0111	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ERAP1—ankylosing spondylitis	0.00357	0.011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CARD9—ankylosing spondylitis	0.00356	0.011	CbGpPWpGaD
Pentosan Polysulfate—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00355	0.00524	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Betamethasone—ankylosing spondylitis	0.00355	0.00524	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—HLA-C—ankylosing spondylitis	0.00352	0.0109	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00349	0.00516	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00348	0.00514	CcSEcCtD
Pentosan Polysulfate—Mood swings—Prednisone—ankylosing spondylitis	0.00348	0.00514	CcSEcCtD
Pentosan Polysulfate—Sweating—Methylprednisolone—ankylosing spondylitis	0.00342	0.00506	CcSEcCtD
Pentosan Polysulfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.00341	0.0106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00341	0.0105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.0034	0.0105	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00338	0.0105	CbGpPWpGaD
Pentosan Polysulfate—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00338	0.00499	CcSEcCtD
Pentosan Polysulfate—Weight increased—Betamethasone—ankylosing spondylitis	0.00331	0.0049	CcSEcCtD
Pentosan Polysulfate—Weight increased—Dexamethasone—ankylosing spondylitis	0.00331	0.0049	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Betamethasone—ankylosing spondylitis	0.00329	0.00487	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00329	0.00487	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CARD9—ankylosing spondylitis	0.00327	0.0101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CARD9—ankylosing spondylitis	0.00325	0.01	CbGpPWpGaD
Pentosan Polysulfate—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00322	0.00476	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00321	0.00475	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00319	0.00471	CcSEcCtD
Pentosan Polysulfate—FGF2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00316	0.00978	CbGpPWpGaD
Pentosan Polysulfate—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00316	0.00467	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00316	0.00467	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.0031	0.00959	CbGpPWpGaD
Pentosan Polysulfate—Sweating increased—Prednisone—ankylosing spondylitis	0.00309	0.00457	CcSEcCtD
Pentosan Polysulfate—Mood swings—Methotrexate—ankylosing spondylitis	0.0029	0.00429	CcSEcCtD
Pentosan Polysulfate—Weight increased—Prednisone—ankylosing spondylitis	0.00289	0.00427	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Prednisone—ankylosing spondylitis	0.00287	0.00424	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00283	0.00418	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00282	0.00417	CcSEcCtD
Pentosan Polysulfate—Depression—Prednisone—ankylosing spondylitis	0.00282	0.00417	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—ANTXR2—ankylosing spondylitis	0.00276	0.00854	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Prednisolone—ankylosing spondylitis	0.00274	0.00405	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00259	0.00384	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00259	0.00383	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00258	0.00797	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Betamethasone—ankylosing spondylitis	0.00258	0.00381	CcSEcCtD
Pentosan Polysulfate—Alopecia—Dexamethasone—ankylosing spondylitis	0.00258	0.00381	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—B3GNT2—ankylosing spondylitis	0.00256	0.00793	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Prednisolone—ankylosing spondylitis	0.00256	0.00378	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00254	0.00376	CcSEcCtD
Pentosan Polysulfate—Malaise—Triamcinolone—ankylosing spondylitis	0.00252	0.00373	CcSEcCtD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.00252	0.00779	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ANTXR2—ankylosing spondylitis	0.00252	0.00779	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Methylprednisolone—ankylosing spondylitis	0.00252	0.00372	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisolone—ankylosing spondylitis	0.00248	0.00367	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00242	0.00358	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.0024	0.00355	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—IL1R2—ankylosing spondylitis	0.00239	0.00739	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Triamcinolone—ankylosing spondylitis	0.00238	0.00352	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00238	0.00351	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00238	0.00351	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—ankylosing spondylitis	0.00236	0.00348	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00235	0.00348	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00235	0.00348	CcSEcCtD
Pentosan Polysulfate—Discomfort—Triamcinolone—ankylosing spondylitis	0.00235	0.00348	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00235	0.00347	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—ankylosing spondylitis	0.0023	0.0034	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.0023	0.0034	CcSEcCtD
Pentosan Polysulfate—Malaise—Betamethasone—ankylosing spondylitis	0.00229	0.00338	CcSEcCtD
Pentosan Polysulfate—Malaise—Dexamethasone—ankylosing spondylitis	0.00229	0.00338	CcSEcCtD
Pentosan Polysulfate—Oedema—Triamcinolone—ankylosing spondylitis	0.00228	0.00337	CcSEcCtD
Pentosan Polysulfate—Infection—Triamcinolone—ankylosing spondylitis	0.00227	0.00335	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—ERAP1—ankylosing spondylitis	0.00227	0.00701	CbGpPWpGaD
Pentosan Polysulfate—Sweating—Methotrexate—ankylosing spondylitis	0.00227	0.00335	CcSEcCtD
Pentosan Polysulfate—Infection—Methylprednisolone—ankylosing spondylitis	0.00226	0.00334	CcSEcCtD
Pentosan Polysulfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.00225	0.00697	CbGpPWpGaD
Pentosan Polysulfate—Haematuria—Methotrexate—ankylosing spondylitis	0.00225	0.00333	CcSEcCtD
Pentosan Polysulfate—Insomnia—Prednisolone—ankylosing spondylitis	0.00224	0.00332	CcSEcCtD
Pentosan Polysulfate—Alopecia—Prednisone—ankylosing spondylitis	0.00224	0.00332	CcSEcCtD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.00224	0.00691	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HLA-C—ankylosing spondylitis	0.00224	0.00691	CbGpPWpGaD
Pentosan Polysulfate—Epistaxis—Methotrexate—ankylosing spondylitis	0.00223	0.00329	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00223	0.00329	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00221	0.00326	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0022	0.00325	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—IL1R2—ankylosing spondylitis	0.00218	0.00674	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Betamethasone—ankylosing spondylitis	0.00216	0.00319	CcSEcCtD
Pentosan Polysulfate—Myalgia—Dexamethasone—ankylosing spondylitis	0.00216	0.00319	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00215	0.00664	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Dexamethasone—ankylosing spondylitis	0.00213	0.00315	CcSEcCtD
Pentosan Polysulfate—Discomfort—Betamethasone—ankylosing spondylitis	0.00213	0.00315	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00211	0.00311	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.0021	0.0065	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HLA-B—ankylosing spondylitis	0.00208	0.00644	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00208	0.00307	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00207	0.00307	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—CARD9—ankylosing spondylitis	0.00207	0.00641	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Betamethasone—ankylosing spondylitis	0.00207	0.00306	CcSEcCtD
Pentosan Polysulfate—Oedema—Dexamethasone—ankylosing spondylitis	0.00207	0.00306	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—ERAP1—ankylosing spondylitis	0.00207	0.00639	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Triamcinolone—ankylosing spondylitis	0.00206	0.00305	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00206	0.00304	CcSEcCtD
Pentosan Polysulfate—Infection—Dexamethasone—ankylosing spondylitis	0.00206	0.00304	CcSEcCtD
Pentosan Polysulfate—Infection—Betamethasone—ankylosing spondylitis	0.00206	0.00304	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—HLA-C—ankylosing spondylitis	0.00205	0.00634	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00205	0.00303	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00205	0.00303	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00204	0.00302	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00204	0.00302	CcSEcCtD
Pentosan Polysulfate—Anaemia—Prednisone—ankylosing spondylitis	0.00204	0.00302	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—HLA-C—ankylosing spondylitis	0.00204	0.0063	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00203	0.00301	CcSEcCtD
Pentosan Polysulfate—Agitation—Prednisone—ankylosing spondylitis	0.00203	0.003	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00203	0.003	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00203	0.003	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00201	0.00297	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.002	0.00296	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.002	0.00296	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.002	0.00296	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.002	0.00618	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Prednisone—ankylosing spondylitis	0.00199	0.00295	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—ankylosing spondylitis	0.00198	0.00292	CcSEcCtD
Pentosan Polysulfate—Anorexia—Betamethasone—ankylosing spondylitis	0.00197	0.00292	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dexamethasone—ankylosing spondylitis	0.00197	0.00292	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisolone—ankylosing spondylitis	0.00197	0.00291	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00196	0.00605	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CARD9—ankylosing spondylitis	0.00189	0.00584	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00189	0.00279	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00189	0.00279	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Prednisone—ankylosing spondylitis	0.00188	0.00278	CcSEcCtD
Pentosan Polysulfate—Myalgia—Prednisone—ankylosing spondylitis	0.00188	0.00278	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00188	0.00278	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00188	0.00277	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—ankylosing spondylitis	0.00187	0.00277	CcSEcCtD
Pentosan Polysulfate—Insomnia—Betamethasone—ankylosing spondylitis	0.00187	0.00277	CcSEcCtD
Pentosan Polysulfate—Insomnia—Dexamethasone—ankylosing spondylitis	0.00187	0.00277	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00186	0.00275	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00186	0.00275	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00186	0.00275	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisone—ankylosing spondylitis	0.00186	0.00275	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.00185	0.00573	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CRP—ankylosing spondylitis	0.00184	0.00569	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00183	0.0027	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00182	0.00269	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00182	0.00269	CcSEcCtD
Pentosan Polysulfate—Urticaria—Triamcinolone—ankylosing spondylitis	0.00181	0.00268	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00181	0.00267	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisone—ankylosing spondylitis	0.0018	0.00267	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0018	0.00266	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0018	0.00266	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0018	0.00266	CcSEcCtD
Pentosan Polysulfate—Infection—Prednisone—ankylosing spondylitis	0.00179	0.00265	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—IL1RN—ankylosing spondylitis	0.00178	0.00551	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—TLR4—ankylosing spondylitis	0.00176	0.00546	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00174	0.00258	CcSEcCtD
Pentosan Polysulfate—Anorexia—Prednisone—ankylosing spondylitis	0.00172	0.00254	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00171	0.00253	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—ankylosing spondylitis	0.00171	0.00252	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00171	0.00252	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00171	0.00252	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00169	0.0025	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00169	0.0025	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00168	0.00249	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00168	0.00248	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—ankylosing spondylitis	0.00167	0.00246	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—ankylosing spondylitis	0.00165	0.00244	CcSEcCtD
Pentosan Polysulfate—Urticaria—Betamethasone—ankylosing spondylitis	0.00165	0.00243	CcSEcCtD
Pentosan Polysulfate—Urticaria—Dexamethasone—ankylosing spondylitis	0.00165	0.00243	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00164	0.00243	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisolone—ankylosing spondylitis	0.00164	0.00243	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00164	0.00506	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00164	0.00242	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00164	0.00242	CcSEcCtD
Pentosan Polysulfate—Insomnia—Prednisone—ankylosing spondylitis	0.00163	0.00241	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—B3GNT2—ankylosing spondylitis	0.00163	0.00503	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Prednisone—ankylosing spondylitis	0.00162	0.00239	CcSEcCtD
Pentosan Polysulfate—Pruritus—Triamcinolone—ankylosing spondylitis	0.00161	0.00239	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00161	0.00238	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Prednisone—ankylosing spondylitis	0.00159	0.00235	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—ankylosing spondylitis	0.00157	0.00232	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—ankylosing spondylitis	0.00157	0.00232	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Prednisone—ankylosing spondylitis	0.00157	0.00232	CcSEcCtD
Pentosan Polysulfate—Rash—Prednisolone—ankylosing spondylitis	0.00156	0.00231	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CD79A—ankylosing spondylitis	0.00156	0.00484	CbGpPWpGaD
Pentosan Polysulfate—Dermatitis—Prednisolone—ankylosing spondylitis	0.00156	0.00231	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00156	0.0023	CcSEcCtD
Pentosan Polysulfate—Headache—Prednisolone—ankylosing spondylitis	0.00155	0.0023	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—ankylosing spondylitis	0.00155	0.0023	CcSEcCtD
Pentosan Polysulfate—Constipation—Prednisone—ankylosing spondylitis	0.00154	0.00228	CcSEcCtD
Pentosan Polysulfate—Dizziness—Triamcinolone—ankylosing spondylitis	0.00151	0.00223	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00151	0.00223	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—ankylosing spondylitis	0.0015	0.00221	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00149	0.00461	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00149	0.0022	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—B3GNT2—ankylosing spondylitis	0.00148	0.00459	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00148	0.00218	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00147	0.00218	CcSEcCtD
Pentosan Polysulfate—Nausea—Prednisolone—ankylosing spondylitis	0.00147	0.00218	CcSEcCtD
Pentosan Polysulfate—Pruritus—Betamethasone—ankylosing spondylitis	0.00147	0.00217	CcSEcCtD
Pentosan Polysulfate—Pruritus—Dexamethasone—ankylosing spondylitis	0.00147	0.00217	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00146	0.00215	CcSEcCtD
Pentosan Polysulfate—Vomiting—Triamcinolone—ankylosing spondylitis	0.00145	0.00214	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00145	0.00214	CcSEcCtD
Pentosan Polysulfate—Rash—Triamcinolone—ankylosing spondylitis	0.00144	0.00213	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00144	0.00213	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—ankylosing spondylitis	0.00144	0.00212	CcSEcCtD
Pentosan Polysulfate—Rash—Methylprednisolone—ankylosing spondylitis	0.00144	0.00212	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00143	0.00212	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisone—ankylosing spondylitis	0.00143	0.00212	CcSEcCtD
Pentosan Polysulfate—Headache—Triamcinolone—ankylosing spondylitis	0.00143	0.00211	CcSEcCtD
Pentosan Polysulfate—Headache—Methylprednisolone—ankylosing spondylitis	0.00143	0.00211	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Prednisone—ankylosing spondylitis	0.00143	0.00211	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00142	0.00209	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00142	0.00209	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00137	0.00203	CcSEcCtD
Pentosan Polysulfate—Dizziness—Betamethasone—ankylosing spondylitis	0.00137	0.00202	CcSEcCtD
Pentosan Polysulfate—Dizziness—Dexamethasone—ankylosing spondylitis	0.00137	0.00202	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—ankylosing spondylitis	0.00136	0.00201	CcSEcCtD
Pentosan Polysulfate—Nausea—Triamcinolone—ankylosing spondylitis	0.00136	0.002	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00135	0.002	CcSEcCtD
Pentosan Polysulfate—Nausea—Methylprednisolone—ankylosing spondylitis	0.00135	0.002	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00134	0.00199	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.00133	0.00413	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00133	0.00196	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00133	0.00196	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—HLA-B—ankylosing spondylitis	0.00132	0.00409	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Dexamethasone—ankylosing spondylitis	0.00132	0.00195	CcSEcCtD
Pentosan Polysulfate—Vomiting—Betamethasone—ankylosing spondylitis	0.00132	0.00195	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00131	0.00194	CcSEcCtD
Pentosan Polysulfate—Rash—Betamethasone—ankylosing spondylitis	0.00131	0.00193	CcSEcCtD
Pentosan Polysulfate—Rash—Dexamethasone—ankylosing spondylitis	0.00131	0.00193	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Betamethasone—ankylosing spondylitis	0.0013	0.00193	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0013	0.00193	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—HLA-C—ankylosing spondylitis	0.0013	0.00402	CbGpPWpGaD
Pentosan Polysulfate—Headache—Dexamethasone—ankylosing spondylitis	0.0013	0.00192	CcSEcCtD
Pentosan Polysulfate—Headache—Betamethasone—ankylosing spondylitis	0.0013	0.00192	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—IL1A—ankylosing spondylitis	0.00128	0.00396	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.00128	0.00396	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Prednisone—ankylosing spondylitis	0.00128	0.00189	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CD40LG—ankylosing spondylitis	0.00128	0.00394	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.00127	0.00392	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00124	0.00184	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Prednisone—ankylosing spondylitis	0.00123	0.00182	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00123	0.00182	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00123	0.00381	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Betamethasone—ankylosing spondylitis	0.00123	0.00182	CcSEcCtD
Pentosan Polysulfate—Nausea—Dexamethasone—ankylosing spondylitis	0.00123	0.00182	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.00122	0.00376	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HLA-B—ankylosing spondylitis	0.00121	0.00375	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HLA-B—ankylosing spondylitis	0.00121	0.00373	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Methotrexate—ankylosing spondylitis	0.0012	0.00177	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisone—ankylosing spondylitis	0.00119	0.00176	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00119	0.00176	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—HLA-C—ankylosing spondylitis	0.00119	0.00367	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.00118	0.00364	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CRP—ankylosing spondylitis	0.00117	0.00361	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.00117	0.00361	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.00116	0.00358	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Prednisone—ankylosing spondylitis	0.00115	0.00169	CcSEcCtD
Pentosan Polysulfate—Rash—Prednisone—ankylosing spondylitis	0.00114	0.00168	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisone—ankylosing spondylitis	0.00114	0.00168	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—IL1RN—ankylosing spondylitis	0.00113	0.0035	CbGpPWpGaD
Pentosan Polysulfate—Headache—Prednisone—ankylosing spondylitis	0.00113	0.00167	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—HLA-A—ankylosing spondylitis	0.00112	0.00347	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—TLR4—ankylosing spondylitis	0.00112	0.00346	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00111	0.00164	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.00107	0.00332	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CRP—ankylosing spondylitis	0.00107	0.00331	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Prednisone—ankylosing spondylitis	0.00107	0.00158	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—ankylosing spondylitis	0.00107	0.00158	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—CRP—ankylosing spondylitis	0.00107	0.00329	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HLA-A—ankylosing spondylitis	0.00104	0.00321	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1RN—ankylosing spondylitis	0.00103	0.00319	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00103	0.00152	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—TLR4—ankylosing spondylitis	0.00103	0.00318	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—TLR4—ankylosing spondylitis	0.00102	0.00316	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Methotrexate—ankylosing spondylitis	0.000997	0.00147	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—CD79A—ankylosing spondylitis	0.000993	0.00307	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Methotrexate—ankylosing spondylitis	0.000958	0.00142	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—ankylosing spondylitis	0.00095	0.0014	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—ankylosing spondylitis	0.000949	0.0014	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—ankylosing spondylitis	0.000944	0.0014	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—CD79A—ankylosing spondylitis	0.000906	0.0028	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Methotrexate—ankylosing spondylitis	0.000895	0.00132	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP3—ankylosing spondylitis	0.000877	0.00271	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1A—ankylosing spondylitis	0.000814	0.00252	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD40LG—ankylosing spondylitis	0.000809	0.0025	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000782	0.00242	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HLA-B—ankylosing spondylitis	0.00077	0.00238	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1A—ankylosing spondylitis	0.000742	0.00229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD40LG—ankylosing spondylitis	0.000738	0.00228	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HLA-A—ankylosing spondylitis	0.000713	0.00221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000713	0.0022	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HLA-B—ankylosing spondylitis	0.000702	0.00217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CRP—ankylosing spondylitis	0.000681	0.0021	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HLA-A—ankylosing spondylitis	0.000659	0.00204	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TLR4—ankylosing spondylitis	0.000653	0.00202	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HLA-A—ankylosing spondylitis	0.000651	0.00201	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CRP—ankylosing spondylitis	0.000621	0.00192	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HLA-A—ankylosing spondylitis	0.000601	0.00186	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TLR4—ankylosing spondylitis	0.000595	0.00184	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000557	0.00172	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—ankylosing spondylitis	0.000546	0.00169	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP3—ankylosing spondylitis	0.000508	0.00157	CbGpPWpGaD
